Thanks to proper intellectual resources made of 170.000 extracts and 15.000 strains and a big potential for the screening activity, the Foundation strongly believes in the possibility of discover and develop new drugs and new therapies.

That’s why the Foundation invests a lot on proper research activities, through a researchers team with great experience coming from Pfizer Vicuron.